Pharma News - Chemdiv

Arcturus Teams With CSL to Develop mRNA Vaccines

For $200 million up front and a possible $4.3 billion later, Arcturus Therapeutics has agreed to a vaccine collaboration with CSL Seqirus.

HLB’s U.S subsidiary scores FDA fast track designation for Merkel cell cancer vaccine

HLB's U.S subsidiary, Immunomic Therapeutics, gets FDA fast track designation for Merkel cell cancer therapeutic, ITI-3000.

FDA Defers Action on Pompe Disease Candidate

The FDA has issued a Deferred Action letter for Amicus Therapeutics’ biologic license application (BLA) for cipaglucosidase alfa, the biologic component of AT-GAA, its investigational dual therap...

Unique genetic signature found by research in different types of cancer

Research led by Dr. Mabel Vidal in the Department of Computer Science at the University of Concepcion, with the collaboration of researchers from MELISA Institute and other academic institutions, i...

Amneal Receives Approval for Leuprolide Acetate

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Admi...

Study suggests oral cephalosporins as safe, effective alternative for treating acute kidney infections

A new study led by Ochsner infectious diseases clinical pharmacist Kevin Lin, PharmD, was recently published in PLoS One, suggesting that oral cephalosporins are as safe and effective as the stand...

Norstella, Citeline merge to create $5bn pharma tech firm

Citeline and Norstella have completed a merger, first announced in June, to create one of the largest players in the pharmaceutical intelligence category.

FDA Turns Down Withdrawal Petition for Lung Cancer Drug Approval

The FDA has rejected a citizen petition calling for withdrawal of accelerated approval for Jazz Pharmaceuticals’ and PharmaMar’s Zepzelca (lurbinectedin), a treatment for adults with metastatic...

Invasive malaria mosquito spreading in Africa, researchers warn

'Major threat': Over 126 million people could be a risk if Anopheles stephensi spreads widely in Africa, research has shown.

A new control system for synthetic genes

Using an approach based on CRISPR proteins, MIT researchers have developed a new way to precisely control the amount of a particular protein that is produced in mammalian cells. ...

New approach increases the likelihood of detecting antiphospholipid syndrome

The Geneva University Hospitals (HUG), the University of Geneva (UNIGE) and their spin-off Endotelix have created the best possible target molecule for the antibodies responsible for antiphospholi...

Researchers unravel how the brain chemical dopamine relates to schizophrenia

Researchers at the Lieber Institute for Brain Development (LIBD) believe they have solved a riddle that has challenged scientists for more than 70 years: how the brain chemical dopamine relates to ...

Pharma News, 2022